Advertisement
Canada markets open in 5 hours 15 minutes
  • S&P/TSX

    21,656.05
    +13.18 (+0.06%)
     
  • S&P 500

    5,022.21
    -29.20 (-0.58%)
     
  • DOW

    37,753.31
    -45.66 (-0.12%)
     
  • CAD/USD

    0.7268
    +0.0005 (+0.07%)
     
  • CRUDE OIL

    82.03
    -0.66 (-0.80%)
     
  • Bitcoin CAD

    83,934.72
    -3,422.84 (-3.92%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,394.00
    +5.60 (+0.23%)
     
  • RUSSELL 2000

    1,947.95
    -19.53 (-0.99%)
     
  • 10-Yr Bond

    4.5850
    0.0000 (0.00%)
     
  • NASDAQ futures

    17,745.00
    +86.50 (+0.49%)
     
  • VOLATILITY

    17.89
    -0.32 (-1.76%)
     
  • FTSE

    7,894.43
    +46.44 (+0.59%)
     
  • NIKKEI 225

    38,079.70
    +117.90 (+0.31%)
     
  • CAD/EUR

    0.6804
    +0.0002 (+0.03%)
     

What Regeneron Pharmaceuticals’ Bottom Line Indicates

What Regeneron Pharmaceuticals’ Bottom Line Indicates

In this year’s third quarter, Regeneron Pharmaceuticals’ (REGN) interest expenses rose YoY (year-over-year) to $7.49 million from $6.18 million, and its net other income rose YoY to $16.43 million from $11.86 million. Its income tax expenses fell YoY to $41.21 million from $177.29 million.